Susquehanna International Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-24,800
| Closed | -$102K | – | 14549 |
|
|
2022
Q1 | $102K | Sell |
24,800
-9,400
| -27% | -$34.1K | ﹤0.01% | 11904 |
|
|
2021
Q4 | $122K | Sell |
34,200
-24,200
| -41% | -$84.6K | ﹤0.01% | 11997 |
|
|
2021
Q3 | $213K | Sell |
58,400
-32,700
| -36% | -$132K | ﹤0.01% | 11358 |
|
|
2021
Q2 | $397K | Buy |
91,100
+19,300
| +27% | +$78.6K | ﹤0.01% | 10160 |
|
|
2021
Q1 | $295K | Sell |
71,800
-56,800
| -44% | -$246K | ﹤0.01% | 10637 |
|
|
2020
Q4 | $513K | Buy |
128,600
+16,800
| +15% | +$54.4K | ﹤0.01% | 8239 |
|
|
2020
Q3 | $302K | Buy |
111,800
+77,400
| +225% | +$214K | ﹤0.01% | 8696 |
|
|
2020
Q2 | $95K | Sell |
34,400
-28,500
| -45% | -$79.5K | ﹤0.01% | 9526 |
|
|
2020
Q1 | $148K | Sell |
62,900
-71,600
| -53% | -$244K | ﹤0.01% | 9003 |
|
|
2019
Q4 | $632K | Sell |
134,500
-133,200
| -50% | -$545K | ﹤0.01% | 6482 |
|
|
2019
Q3 | $895K | Sell |
267,700
-48,400
| -15% | -$159K | ﹤0.01% | 5921 |
|
|
2019
Q2 | $1.04M | Buy |
316,100
+3,400
| +1% | +$9.84K | ﹤0.01% | 5560 |
|
|
2019
Q1 | $947K | Buy |
312,700
+109,700
| +54% | +$356K | ﹤0.01% | 5149 |
|
|
2018
Q4 | $552K | Buy |
203,000
+182,300
| +881% | +$601K | ﹤0.01% | 5836 |
|
|
2018
Q3 | $70K | Sell |
20,700
-32,000
| -61% | -$98.8K | ﹤0.01% | 8741 |
|
|
2018
Q2 | $136K | Buy |
52,700
+24,100
| +84% | +$60K | ﹤0.01% | 8907 |
|
|
2018
Q1 | $63K | Buy |
28,600
+6,100
| +27% | +$13.7K | ﹤0.01% | 8888 |
|
|
2017
Q4 | $45K | Sell |
22,500
-42,200
| -65% | -$91.8K | ﹤0.01% | 8938 |
|
|
2017
Q3 | $210K | Buy |
64,700
+34,200
| +112% | +$106K | ﹤0.01% | 7941 |
|
|
2017
Q2 | $98K | Buy |
30,500
+5,200
| +21% | +$14.7K | ﹤0.01% | 8697 |
|
|
2017
Q1 | $72K | Buy |
25,300
+14,300
| +130% | +$34.4K | ﹤0.01% | 8504 |
|
|
2016
Q4 | $26K | Buy |
+11,000
| New | +$20.9K | ﹤0.01% | 9399 |
|
|
2015
Q4 | – | Sell |
-15,100
| Closed | -$26K | – | 10185 |
|
|
2015
Q3 | $26K | Sell |
15,100
-26,100
| -63% | -$51.2K | ﹤0.01% | 9466 |
|
|
2015
Q2 | $86K | Sell |
41,200
-59,000
| -59% | -$143K | ﹤0.01% | 9725 |
|
|
2015
Q1 | $272K | Sell |
100,200
-10,600
| -10% | -$26.9K | ﹤0.01% | 8143 |
|
|
2014
Q4 | $285K | Sell |
110,800
-74,300
| -40% | -$167K | ﹤0.01% | 8215 |
|
|
2014
Q3 | $339K | Buy |
185,100
+400
| +0.2% | +$872 | ﹤0.01% | 7834 |
|
|
2014
Q2 | $493K | Buy |
184,700
+25,100
| +16% | +$75.5K | ﹤0.01% | 7512 |
|
|
2014
Q1 | $559K | Buy |
159,600
+47,900
| +43% | +$213K | ﹤0.01% | 6553 |
|
|
2013
Q4 | $500K | Buy |
111,700
+34,200
| +44% | +$139K | ﹤0.01% | 6696 |
|
|
2013
Q3 | $314K | Buy |
77,500
+25,400
| +49% | +$111K | ﹤0.01% | 7141 |
|
|
2013
Q2 | $217K | Buy |
+52,100
| New | +$201K | ﹤0.01% | 7316 |
|
Other funds holding ATRS
Susquehanna International Group's ATRS Position: Q2 2022 in Review
Susquehanna International Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 212,194 shares — an estimated $870K sold.
Susquehanna International Group first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $1.97M in Q1 2017. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Susquehanna International Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Susquehanna International Group sold 212,194 Antares Pharma, Inc. shares in Q2 2022, an estimated $870K.
- Susquehanna International Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- Susquehanna International Group's Antares Pharma, Inc. position peaked at $1.97M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.